Sudeep Pharma Limited (SUDEEPPHRM) Financial History

Name: Sudeep Pharma Limited (SUDEEPPHRM) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Sudeep Pharma Limited (SUDEEPPHRM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Vadodara, India with about 525 employees. Its market capitalization is roughly ₹130 billion. In the fiscal year ended 2026-03-31, SUDEEPPHRM reported ₹6.4B in revenue and ₹1.7B in net income.

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in India, the United States, and internationally.

Interactive charts & full statements →

SUDEEPPHRM Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹6.4B	₹5.0B	₹4.5B	₹4.3B
Gross Profit	₹4.0B	₹3.3B	₹2.8B	₹2.4B
Operating Income (EBIT)	₹2.1B	₹1.8B	₹1.7B	₹839M
Net Income	₹1.7B	₹1.4B	₹1.3B	₹623M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SUDEEPPHRM Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹1.6B	₹1.8B	₹1.7B	₹1.2B	₹1.6B	—
Gross Profit	₹1.0B	₹1.2B	₹1.1B	₹826M	₹978M	—
Operating Income (EBIT)	₹509M	₹587M	₹561M	₹406M	₹560M	—
Net Income	₹406M	₹489M	₹475M	₹308M	₹442M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SUDEEPPHRM Free Cash Flow History

SUDEEPPHRM Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	₹11.7B	₹7.2B	₹5.1B	₹4.2B
Total Liabilities	₹2.8B	₹2.2B	₹1.6B	₹2.0B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SUDEEPPHRM viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

COHANCE · Cohance Lifesciences Limited — ₹168 billion
APLLTD · Alembic Pharmaceuticals Limited — ₹166 billion
4521 · Kaken Pharmaceutical Co., Ltd. — JPY 151 billion
NATCOPHARM · NATCO Pharma Limited — ₹148 billion
AKUMS · Akums Drugs and Pharmaceuticals Limited — ₹120 billion
4534 · Mochida Pharmaceutical Co., Ltd. — JPY 116 billion
STAR · Strides Pharma Science Limited — ₹112 billion
VIYASH · Viyash Scientific Limited — ₹110 billion

← SUDARSCHEM All “S” companies SUEC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.